← All stocks

Pyxis Oncology, Inc.

PYXS Net buying

CIK 0001782223 #3722 in the set updated 20 Sep 2026

Bought (120 mo)

$17.74M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$5.53M

$15.92K on a plan · $107.10K straight out of an exercise

Sold at will

$5.41M

6 of 10 sales

Net

+$12.21M

+$12.34M against sales at will

By person

15 insiders · 24 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Cormorant Asset Management, LP entity

Former 10% Owner

$7.20M (1)

—

+$7.20M

1,118,854

1.34%

$3.42M

—

PFIZER INC entity

10% owner

$5.00M (1)

—

+$5.00M

5,952,263

7.14%

$18.21M

+43.8%

Chin Mark

Former Director

$5.00M (1)

$5.32M (1)

−$324.57K

66,831

0.0801%

$204.50K

—

Connealy Pamela Ann

CFO & COO

$229.93K (6)

—

+$229.93K

2,309,436

2.77%

$7.07M

+107.1%

Civik Thomas

CEO & Chairman of the Board

$200.02K (1)

—

+$200.02K

221,886

0.2660%

$678.97K

—

Dupont Jakob

Director

—

$107.10K (1) scheduled

−$107.10K

38,741

0.0464%

$118.55K

—

Cline Darren S

Director

$93.89K (1)

—

+$93.89K

251,405

0.3014%

$769.30K

—

Sullivan Lara

President ,CEO & CMO

—

$81.46K (5)

−$81.46K

2,403,882

2.88%

$7.36M

+704.5%

Wadhane Jitendra

Prin Fin & Acct Officer

$17.87K (3)

—

+$17.87K

512,882

0.6149%

$1.57M

+856.0%

HUMPHREY RACHEL

Director

—

$15.92K (3) scheduled

−$15.92K

81,309

0.0975%

$248.81K

—

Bayer World Investments B.V. entity

Former 10% Owner

—

2,742,338

3.29%

$8.39M

—

Feingold Jay

Chief Medical Officer

—

730,345

0.8756%

$2.23M

—

FLAVIN JOHN L

Director

—

413,015

0.4952%

$1.26M

+144.1%

Lewis-Hall Freda C

Director

—

241,405

0.2894%

$738.70K

—

Palani Santhosh

Director

—

6,000

0.0072%

$18.36K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

HUMPHREY RACHEL

21 Apr 2025

Director

Sold on a plan

13,896

$1.03

$14.36K

HUMPHREY RACHEL

17 Apr 2025

Director

Sold on a plan

200

$0.97

$194.00

HUMPHREY RACHEL

14 Apr 2025

Director

Sold on a plan

1,400

$0.97

$1.36K

Show all 24 transactions →

What was left out

Form 4 filings counted 101

Amendments (4/A) skipped 1

Filings about a different issuer 0

Unreadable filings 0

Joint filings 3

Sales on a Rule 10b5-1 plan 3

Sales straight out of an exercise 1

Sales at will 6

Transactions with no price 0

Shares from compensation/vesting 10,859,098

Sales filed before the plan box existed 1

History held since 12 Oct 2021